Related Experiment Video
Updated: Jan 10, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Preoperative risk factors associated with hypoglycemia after bariatric surgery: a systematic review and meta-analysis
Lisa Milena Anabela1, Syifa Salsabila1, Wilbert Huang1
1Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Background:
Hypoglycemia is a common adverse outcome after bariatric surgery. Preoperative factors are important to predict worse hypoglycemic incidence. This study aimed to evaluate preoperative risk factors associated with the incidence of hypoglycemia after bariatric surgery.
Methods:
A systematic search was performed across 3 databases until September 2024. Hypoglycemia was defined as the presence of neuroglycopenic and/or neurogenic signs and symptoms, accompanied by a blood glucose level of <3.0 mmol/L (54 mg/dL) with resolution after glucose ingestion.
Results:
A total of 11 observational and randomized controlled trial studies, which were composed of 8428 patients, were included in the study. Female sex (odds ratio [OR] 1.56, [95% CI, 1.28-1.89]; P <.00001; I2 = 0%) and body mass index (BMI; OR, 1.03 [95% CI, 1.01-1.05]; P =.002; I2 = 0%) were associated with an increased risk of developing hypoglycemia after bariatric surgery. Preoperative fasting blood glucose value was associated with increased odds of hypoglycemia (OR, 3.16 [95% CI, 1.34-7.44]; P =.008; I2 = 83%; r, -492 [range, -0.572 to -402]; P =.000). Age, hemoglobin A1C level, high-density lipoprotein cholesterol, triglycerides, and preoperative smoking status were not significantly associated with the increased odds of postbariatric hypoglycemia (PBH) or linearly correlated with the outcome (P >.05).
Conclusion:
Female sex, BMI, and preoperative fasting blood glucose level were significantly associated with the incidence of PBH. A lower preoperative fasting blood glucose level increased the risk of PBH.
Related Concept Videos
Hypoglycemia and Glucagon
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Glinides
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

